Policy & Advocacy
We leverage on our standing relationships within the policy environment to engage with and inform policies towards an enabling business environment in the health and pharmaceutical industry. Through the dedicated efforts of the working committees, KAPI has provided timely feedback on varied regulations and guidelines influencing the ways of working on the operational activities on pharmaceutical and medical devices areas of interest.
01.
Position papers
KAPI working with the vibrant committees has developed position papers on emerging guidelines and policies on healthcare, financing, parallel importation, regulatory system strengthening, Price Control Bill, Strategic Good Control Bill
- Quality of Health Care and Patient Safety Bill 2025
- Position Statement on Draft Guidelines for Renewals of Medicines and Vaccines
- Position Statement on Draft Guideline For Submission of Variation Applications For Registered Biotherapeutic Products
- KAPI Recommendations on the Guideline for Submission of Variation Applications for Registered Human Products